Baillie Gifford acquired 8.16 Million BioNTech SE shares worth $773 Million. That's 0.64% of their equity portfolio (31st largest holding). The investor owns 3.07% of the outstanding BioNTech SE stock. The first BioNTech SE trade was made in Q1 2021. Since then Baillie Gifford bought shares seven more times and sold shares on nine occasions. The investor's estimated purchase price is $949 Million, resulting in a loss of 19%.